Immunology Division, Garvan Institute of Medical Research, Sydney, Australia; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia.
Immunology Division, Garvan Institute of Medical Research, Sydney, Australia; Department of Biology and Biochemistry, Faculty of Science, University of Bath, Bath, UK.
Trends Immunol. 2019 Jan;40(1):35-48. doi: 10.1016/j.it.2018.11.004. Epub 2018 Nov 27.
Subcapsular sinus (SCS) macrophages are strategically positioned at the lymph-tissue interface in the lymph node to trap and present antigen to B cells. Recent murine data has shown that SCS macrophages also prevent the systemic spread of lymph-borne pathogens and are capable of activating a diverse range of innate effector and adaptive memory cells, including follicular memory T cells and memory B cells (B), that are either pre-positioned or rapidly recruited to the subcapsular niche following infection and inflammation. Furthermore, B are rapidly reactivated to differentiate into plasma cells in subcapsular proliferative foci (SPF). Thus, understanding how SCS macrophages coordinate both innate and adaptive memory responses in the subcapsular niche can provide new opportunities to bolster immunity against pathogens and cancer.
被膜下窦(SCS)巨噬细胞位于淋巴结的淋巴组织界面处,处于战略位置,可捕获并向 B 细胞呈递抗原。最近的小鼠数据表明,SCS 巨噬细胞还可以防止淋巴传播病原体的全身扩散,并能够激活多种先天效应和适应性记忆细胞,包括滤泡性记忆 T 细胞和记忆 B 细胞(B 细胞),这些细胞要么预先定位于或在感染和炎症后迅速募集到被膜下腔隙。此外,B 细胞在被膜下增殖灶(SPF)中迅速被激活分化为浆细胞。因此,了解 SCS 巨噬细胞如何在被膜下腔隙中协调先天和适应性记忆反应,可为增强对病原体和癌症的免疫力提供新的机会。